Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613
This examiner grants 37% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17903586 | COMPOSITIONS AND METHODS FOR STABILIZING BIOMOLECULES | Non-Final OA | Massachusetts Institute of Technology |
| 18262443 | SYNTHETIC ARTIFICIAL STEM CELLS (SASC) | Final Rejection | UNIVERSITY OF CONNECTICUT |
| 18380984 | NanoMesh Drug Delivery for Treatment of Brain Tumors | Non-Final OA | The Johns Hopkins University |
| 18550371 | DELIVERY OF MACROMOLECULES USING MICROINJECTORS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18544312 | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER | Non-Final OA | L'OREAL |
| 17778353 | PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF POLYMER(S)AND A COLORING AGENT | Final Rejection | L'OREAL |
| 18540213 | HAIR COSMETIC COMPOSITION | Non-Final OA | KAO CORPORATION |
| 17425981 | ORODISPERSIBLE TABLET | Final Rejection | Reckitt Benckiser Health Limited |
| 18694533 | PERSONAL CARE COMPOSITIONS HAVING ENHANCED ANTIOXIDANT PERFORMANCE | Non-Final OA | Edgewell Personal Care Brands, LLC |
| 18368437 | SILICONE FREE COSMETIC COMPOSITION | Final Rejection | SHISEIDO COMPANY, LTD. |
| 18419387 | TYRAMINE CONTAINING HYDROXYCINNAMIC ACID AMIDE DERIVATIVES AND METHODS OF USE THEREOF | Non-Final OA | Sanford Burnham Prebys Medical Discovery Institute |
| 17428111 | METAL (HYDR)OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | CNPHARM CO., LTD |
| 17672988 | MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES | Final Rejection | Quicksilver Scientific, Inc. |
| 18247363 | ACETIC ACID AS PROCESSING AID IN SPRAY DRYING FOR BASIC DRUGS | Final Rejection | Lonza Bend Inc. |
| 17421265 | ORAL THIN FILM | Non-Final OA | LTS LOHMANN THERAPIE-SYSTEME AG |
| 18683162 | AQUEOUS PERSONAL CARE COMPOSITIONS COMPRISING CARBOXYMETHYL CELLULOSE (CMC), PROCESS FOR PREPARING THE SAME AND USE THEREOF | Non-Final OA | ISP Investments LLC |
| 18391869 | TARGETING OF ANTIGEN-PRESENTING CELLS BY NANOPARTICLES CONTAINING POLYOXAZOLINE-LIPID CONJUGATES | Non-Final OA | Serina Therapeutics, Inc. |
| 18286990 | HAIR SERUM AND SUPPLEMENT | Non-Final OA | CS MEDICA A/S |
| 18562271 | PREPARATION IN SOLID FORM COMPRISING ACTIVATED CARBON AND CHITOSAN, METHOD FOR PREPARING SAID PREPARATION, COMPOSITION COMPRISING SAID PREPARATION AND USES OF SAID COMPOSITION | Non-Final OA | S.I.I.T. S.R.L. - SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI |
| 18510293 | ACARICIDE HETERODISSEMINATION BY SMALL MAMMALS | Non-Final OA | BanfieldBio Inc. |
| 18209195 | AMINO ALCOHOL IONIZABLE LIPIDS | Non-Final OA | NEW JERSEY INSTITUTE OF TECHNOLOGY |
| 18505809 | COMPOSITIONS FOR THE TREATMENT OF A DISEASE OF THE URINARY TRACT AND TREATMENT OF A DISEASE INVOLVING THE INTRACELLULAR DELIVERY OF THE PARTICLE OR A MEDICAMENT CONTAINED THEREIN | Non-Final OA | UCL BUSINESS LTD |
| 18278082 | SILK FIBROIN BIOINKS AND RELATED USE FOR 3D BIOPRINTING | Final Rejection | CELLINK |
| 18451462 | PSEUDO-TERNARY PHASE SYSTEM FOR IMPROVING SOLUBILITY OF A PHARMACEUTICALLY ACTIVE INGREDIENT | Non-Final OA | Hepion Pharmaceuticals, Inc. |
| 18277403 | ANTI-PATHOGENIC LIQUID COMPOSITIONS | Non-Final OA | CLAW Biotech Holdings, LLC |
| 18263150 | CONCENTRATE CONTAINING POORLY SOLUBLE DRUG AND EMULSION PREPARED THEREFROM | Final Rejection | BEIJING DELIVERY PHARMACEUTICAL TECHNOLOGY CO., LTD |
| 17951981 | SYSTEMS, METHODS, AND COMPOSITIONS FOR INFECTIONS | Final Rejection | Ojai Energetics PBC |
| 18142459 | NOVEL LIPID-BASED CARRIER COMPOSITION SMALL MOLECULE INTEGRIN RECEPTOR-LIGAND AGONIST ADJUVANTS PHARMACEUTICAL COMPOSITIONS THEREFROM, AND METHODS FOR MAKING AND USING SAME | Final Rejection | 7 Hills Pharma Inc. |
| 18023403 | POLY HYDROXY OLIGOMER COATED DOLUTEGRAVIR AQUASOMES AND METHOD THEREOF | Non-Final OA | Varalakshmi MUMMIDI |
| 18007368 | MICROEMULSION DRUG DELIVERY SYSTEM FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME | Non-Final OA | Council for Scientific and Industrial Research |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy